Human B7-1/CD80 Antibody Summary
Val35-Asn242 (predicted)
Accession # P33681
Applications
Human B7-1/CD80 Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of B7‑1/CD80 in Raji Human Cell Line by Flow Cytometry. Raji human Burkitt's lymphoma cell line was stained with Mouse Anti-Human B7-1/CD80 Monoclonal Antibody (Catalog # MAB140, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Fluorescein-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0103B). View our protocol for Staining Membrane-associated Proteins.
IL‑2 secretion Induced by B7‑1/CD80 and Neutralization by Human B7‑1/CD80 Antibody. Recombinant Human B7-1/CD80 Fc Chimera (Catalog # 140-B1) co-stimulates IL-2 secretion in the Jurkat human acute T cell leukemia cell line in the presence of PHA in a dose-dependent manner (orange line), as measured by the Human IL-2 Quantikine ELISA Kit (Catalog # D2050). IL-2 secretion elicited by Recombinant Human B7-1/CD80 Fc Chimera (1 µg/mL) and PHA (10 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human B7-1/CD80 Monoclonal Antibody (Catalog # MAB140). The ND50 is typically 0.2-1 µg/mL.
B7‑1/CD80 in Human Tonsil. B7-1/CD80 was detected in immersion fixed paraffin-embedded sections of human tonsil using Mouse Anti-Human B7-1/CD80 Monoclonal Antibody (Catalog # MAB140) at 5 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Mouse HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS002) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in lymphocytes. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
B7-1/CD80 in Human Tonsil Using Dual RNAscope®ISH and IHC. B7-1/CD80 mRNA was detected in formalin-fixed paraffin-embedded tissue sections of human tonsil probed with ACD RNAScope®Probe (Catalog # 42471) and stained using ACD RNAscope®2.5 HD Duplex Detection Reagents (red, Catalog # 322500). Adjacent tissue section was processed for immunohistochemistry using R&D Systems Mouse Anti-Human B7-1/CD80 Monoclonal Antibody (Catalog# MAB140) at 5ug/mL with overnight incubation at 4 °C followed by incubation with the Anti-Mouse IgG VisUCyte HRP Polymer Antibody (R&D Systems, Catalog # VC001) and DAB chromogen (lower image, brown). Tissues were counterstained with hematoxylin (blue).
Detection of Mouse B7-1/CD80 by Immunohistochemistry MNK inhibitors induce polarization of TAMs toward an M2 phenotype in ex vivo human PDAC slice cultures.(A) Serial sections of human PDAC tumors (n = 15) were stained for Arginase-1 and phosphorylated eIF4ES209 (p-eIF4E) by IHC. Scale bar: 200 μm. The staining positivity was analyzed by the TissueGnostics Imaging system using the HistoQuest, and the correlation analysis for Arginase-1 and p-eIF4E expression was performed using GraphPad. (B) Slice cultures (n = 1–4 replicates for each treatment group) from 6 different PDAC tumors were treated with DMSO (vehicle control) or CGP57380 for 5 days and stained for phosphorylated eIF4E (p-eIF4E), CD68, Arginase-1, CD163, MRC1, CD86, CD80, and MHCII. The percentage of positive cells, relative to the total number of nucleated cells, was analyzed by ImageJ. Scale bar: 50 μm. Data points represent individual patients. Paired t test was performed by GraphPad. *P < 0.05; **P < 0.01. (C) The relative expression of MKNK2, CD163, and MRC1 in TCGA studies and their transcript abundance from RNA-Seq data, quantified as RSEM, were downloaded from cBioPortal. Correlation analysis was performed in GraphPad to evaluate the relationship between MKNK2, CD163, and MRC1. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/35380995), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: B7-1/CD80
B7-1 and B7-2, together with their receptors CD28 and CTLA-4, constitute one of the dominant co-stimulatory pathways that regulate T- and B-cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20‑100 fold higher affinity than CD28 and is involved in the down‑regulation of the immune response. B7-1 is expressed on activated B cells, activated T cells, and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Additionally, B7-2 is expressed at low levels on monocytes and can be up‑regulated through Interferon gamma. B7-1 and B7-2 are both members of the Immunoglobulin superfamily. Human B7-1 is a 288 amino acid (aa) protein containing a 34 aa signal peptide, a 208 aa extracellular domain, a 21 aa transmembrane domain, and a 25 aa cytoplasmic domain. Human B7-1 and B7-2 share 26% aa sequenceidentity. Human and mouse B7-1 share 44% aa sequenceidentity. However, it has been observed that both human and mouse B7-1 and B7-2 can bind to either human or mouse CD28 and CTLA-4, suggesting that there are conserved amino acids which form the B7-1/B7-2/CD28/CTLA-4 critical binding sites.
- Azuma, M. et al. (1993) Nature 366:76.
- Freeman, G.J. et al. (1993) Science 262:909.
- Freeman, G. et al. (1991) J. Exp. Med. 174:625.
- Selvakumar, A. et al. (1993) Immunogenetics 38:292.
- Chen, C. et al. (1994) J. Immunol. 152:4929.
- Freeman, G.J. et al. (1993) J. Exp. Med. 178:2185.
Product Datasheets
Citations for Human B7-1/CD80 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
26
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease
Authors: Mikio Shiba, Yasuo Sugano, Yoshihiko Ikeda, Hideshi Okada, Toshiyuki Nagai, Hatsue Ishibashi-Ueda et al.
PLOS ONE
-
Increased extracellular vesicles (EVs) related to T cell-mediated inflammation and vascular function in familial hypercholesterolemia
Authors: Morten Hjuler Nielsen, Rikke Bæk, Malene Moller Jorgensen, Maiken Mellergaard, Aase Handberg
Atherosclerosis Plus
-
The human tissue-biomaterial interface: a role for PPAR gamma -dependent glucocorticoid receptor activation in regulating the CD163+ M2 macrophage phenotype
Authors: Samuel J. Bullers, Simon C. Baker, Eileen Ingham, Jennifer Southgate
Tissue Engineering Part A
-
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1
Authors: Patricia Kleinpeter, Christelle Remy-Ziller, Eline Winter, Murielle Gantzer, Virginie Nourtier, Juliette Kempf et al.
Journal of Virology
-
The immunophenotype of decidual macrophages in acute atherosis
Authors: Navleen Gill, Yaozhu Leng, Roberto Romero, Yi Xu, Bogdan Panaitescu, Derek Miller et al.
American Journal of Reproductive Immunology
-
B7–1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy
Authors: Elena Gagliardini, Rubina Novelli, Daniela Corna, Carlamaria Zoja, Barbara Ruggiero, Ariela Benigni et al.
Journal of the American Society of Nephrology
-
Human Vascularized Macrophage-Islet Organoids to Model Immune-Mediated Pancreatic ? cell Pyroptosis upon Viral Infection
Authors: Yang, L;Han, Y;Zhang, T;Dong, X;Ge, J;Roy, A;Zhu, J;Lu, T;Vandana, JJ;de Silva, N;Robertson, CC;Xiang, JZ;Pan, C;Sun, Y;Que, J;Evans, T;Liu, C;Wang, W;Naji, A;Parker, SCJ;Schwartz, RE;Chen, S;
bioRxiv : the preprint server for biology
Species: Human
Sample Types: Whole Tissue
Applications: Immunohistochemistry -
Potential Role of Macrophage Polarization in the Progression of Hunner-Type Interstitial Cystitis
Authors: Ko, KJ;Kim, G;Sung, HH;Park, WY;Lee, KS;
International journal of molecular sciences
Species: Human
Sample Types: Whole Tissues
Applications: IHC -
Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
Authors: S Shankar, J Stolp, SC Juvet, J Beckett, PS Macklin, F Issa, J Hester, KJ Wood
Nature Communications, 2022-06-03;13(1):3121.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Inhibiting MNK kinases promotes macrophage immunosuppressive phenotype to limit CD8+ T cell anti-tumor immunity
Authors: TN Pham, C Spaulding, MA Shields, AE Metropulos, DN Shah, MG Khalafalla, DR Principe, DJ Bentrem, HG Munshi
JCI Insight, 2022-05-09;0(0):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
B7-1 and programmed cell death-ligand 1 in primary and lymph node metastasis lesions of non-small cell lung carcinoma
Authors: T Yamada, Y Miki, M Suzuki, O Kondoh, R Saito-Koya, K Ono, Y Okada, H Sasano
Cancer Medicine, 2021-12-14;0(0):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
Authors: Y Liu, S He, XL Wang, W Peng, QY Chen, DM Chi, JR Chen, BW Han, GW Lin, YQ Li, QY Wang, RJ Peng, PP Wei, X Guo, B Li, X Xia, HQ Mai, XD Hu, Z Zhang, YX Zeng, JX Bei
Nature Communications, 2021-02-02;12(1):741.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Authors: B Diskin, S Adam, MF Cassini, G Sanchez, M Liria, B Aykut, C Buttar, E Li, B Sundberg, RD Salas, R Chen, J Wang, M Kim, MS Farooq, S Nguy, C Fedele, KH Tang, T Chen, W Wang, M Hundeyin, JAK Rossi, E Kurz, MIU Haq, J Karlen, E Kruger, Z Sekendiz, D Wu, SAA Shadaloey, G Baptiste, G Werba, S Selvaraj, C Loomis, KK Wong, J Leinwand, G Miller
Nat. Immunol., 2020-03-09;21(4):442-454.
Species: Human, Mouse
Sample Types: Whole Cells
Applications: T Cell Activation -
The utility of urinary CD80 as a diagnostic marker in patients with renal diseases
Authors: S Minamikawa, K Nozu, S Maeta, T Yamamura, K Nakanishi, J Fujimura, T Horinouchi, C Nagano, N Sakakibara, H Nagase, H Shima, K Noda, T Ninchoji, H Kaito, K Iijima
Sci Rep, 2018-11-23;8(1):17322.
Species: Human
Sample Types: Urine
Applications: ELISA Development (Detection) -
Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord
Authors: J Li, SQ Xu, YM Zhao, S Yu, LH Ge, BH Xu
Mol Med Rep, 2018-09-20;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis
Authors: S He, C Wu, J Xiao, D Li, Z Sun, M Li
Scand. J. Immunol., 2018-04-01;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Tubular B7-1 expression parallels proteinuria levels, but not clinical outcomes in adult minimal change disease patients
Authors: SW Lee, SH Baek, JH Paik, S Kim, KY Na, DW Chae, HJ Chin
Sci Rep, 2017-02-02;7(0):41859.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Autoantibodies against CD80 in patients with COPD
Authors: Xiongbiao Wang
Clin Transl Immunology, 2016-10-07;5(10):e103.
Species: Human
Sample Types: Serum
Applications: Western Blot -
Tumor-activated TCRgammadelta(+) T cells from gastric cancer patients induce the antitumor immune response of TCRalphabeta(+) T cells via their antigen-presenting cell-like effects.
Authors: Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, Zheng T, Tong J, Wang S, Chen D
J Immunol Res, 2014-03-31;2014(0):593562.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay -
B7-CD28 costimulatory signals control the survival and proliferation of murine and human gammadelta T cells via IL-2 production.
J. Immunol., 2012-06-25;189(3):1202-8.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.
Blood, 2012-05-10;119(26):6268-77.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
A synergistic antitumor effect of interleukin-2 addition with CD80 immunogene therapy for peritoneal metastasis of gastric carcinoma.
Authors: Kosaka K, Yashiro M, Sakate Y, Hirakawa K
Dig. Dis. Sci., 2007-04-03;52(8):1946-53.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury
Authors: Min Zhang, Kojiro Nakamura, Shoichi Kageyama, Akeem O. Lawal, Ke Wei Gong, May Bhetraratana et al.
JCI Insight
-
CD80 expression promotes immune surveillance in Barrett’s metaplasia
Authors: Melania Scarpa, Matteo Fassan, Andromachi Kotsafti, Stefano Realdon, Luigi Dall’Olmo, Tiziana Morbin et al.
OncoImmunology
-
Activated macrophages promote invasion by early colorectal cancer via an interleukin 1 beta ‐serum amyloid A1 axis
Authors: Gota Sudo, Hironori Aoki, Eiichiro Yamamoto, Akira Takasawa, Takeshi Niinuma, Ayano Yoshido et al.
Cancer Science
-
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
Authors: Matteo Fassan, Francesco Cavallin, Vincenza Guzzardo, Andromachi Kotsafti, Melania Scarpa, Matteo Cagol et al.
Cancer Medicine
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human B7-1/CD80 Antibody
Average Rating: 3.5 (Based on 2 Reviews)
Have you used Human B7-1/CD80 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: